Advertisement Perrigo acquires Galpharm Healthcare - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Perrigo acquires Galpharm Healthcare

US-based Perrigo, a global healthcare manufacturer and supplier of OTC products, has acquired Galpharm Healthcare for $86 million in cash.

The acquisition is expected to add more than $55 million in sales annually and be accretive to earnings in the first year.

Joseph Papa, chairman and CEO of Perrigo, said: “The acquisition of Galpharm further expands our global presence, complements our existing UK business and increases value for our shareholders. It also helps us meet the world’s growing need for quality, affordable healthcare.”